Schedule 13G ownership disclosure

ZYNERBA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98986X109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
788,372
Percent of class
9.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000909012-15-000285
Form type
SC 13G
Filer
Benovitz Ethan
CIK
CIK 1546198
Filed
Aug 14, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub